Drug – bio-affecting and body treating compositions – Solid synthetic organic polymer as designated organic active... – Ion exchange resin
Reexamination Certificate
2011-06-21
2011-06-21
Kosar, Andrew D (Department: 1654)
Drug, bio-affecting and body treating compositions
Solid synthetic organic polymer as designated organic active...
Ion exchange resin
C424S001690, C514S043000, C530S332000, C530S333000
Reexamination Certificate
active
07964181
ABSTRACT:
Ring-constrained amino acid surrogates of formula I:where R1, R2, R3, R4, R5, R6a, R6b, R7, and y are as defined in the specification, methods for synthesizing ring-constrained amino acid surrogates of formula I, methods of use of ring-constrained amino acid surrogates of formula I, including use in linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I and linear or cyclic compounds which include a plurality of amino acid residues and one or more ring-constrained amino acid surrogates of formula I.
REFERENCES:
patent: 4251438 (1981-02-01), Moon
patent: 4341698 (1982-07-01), Carr et al.
patent: 5559232 (1996-09-01), Ackermann et al.
patent: 5929237 (1999-07-01), Kahn
patent: 6013458 (2000-01-01), Kahn et al.
patent: 6184223 (2001-02-01), Kahn et al.
patent: 6413963 (2002-07-01), Kahn et al.
patent: 6462046 (2002-10-01), Lou et al.
patent: 6943157 (2005-09-01), Nagula et al.
patent: 7008941 (2006-03-01), Urban et al.
patent: 2002/0111348 (2002-08-01), Reichard et al.
patent: 2003/0019049 (2003-01-01), Kravtchenko et al.
patent: 2004/0224957 (2004-11-01), Sharma
patent: 2006/0217532 (2006-09-01), Miao et al.
patent: 2006/0234923 (2006-10-01), Zumbrunn et al.
patent: 3022401 (1981-01-01), None
patent: 2717484 (1995-09-01), None
patent: WO 92/21361 (1992-12-01), None
patent: WO 99/43662 (1999-09-01), None
patent: WO 99/48913 (1999-09-01), None
patent: WO 99/55684 (1999-11-01), None
patent: WO-02/85925 (2002-10-01), None
patent: WO 02/085925 (2002-10-01), None
patent: WO 2007/115175 (2007-10-01), None
patent: WO 2007/115182 (2007-10-01), None
Tong, 1998, Bioorganic and Medicinal Chemistry Letters, 8, 1679-1682.
Su, 2003, Bioorganic and Medicinal Chemistry Letters, 13, 1679-1682.
Mohammad, 1998, Tetrahedron Letters, 39, 8213-8216.
Kolter, 1995, Liebigs Ann., 625-629.
DiMaio, 1989, J. Chem. Soc. Perkin Trans, 1687-1689.
Rubsam, 2000, Tetrahedron, 56, 8481-8487.
Goff, 1996, Tetrahedron Letters, 37, 6247-6250.
Shigematsu, 1988, Tetrahedron Letters, 29, 5147-5150.
Masuzawa, et al., The Reaction of C-Substituted Ethylenediamine with the Ester of Alpha-Halo Acid, vol. 38, No. 12, 2078-2081 (1965).
PCT International Preliminary Report on Patentability in PCT/US2007/065632 dated Mar. 3, 2009.
S.M. Hecht, Bioorganic Chemistry: Peptides and Proteins, Oxford University Press, 1998, 395-419.
Rubsam, F., et al., Synthesis of chiral piperazinones as versatile scaffolds for peptidomimetics, Tetrahedron, 2000, 56(43) 8481-8487.
Kolter, T., et al., Synthesis of substituted chiral piperazinones as building blocks for peptidomimetics, Liebigs Annalen, 1995, 4, 625-629.
DiMaio, John, et al., Synthesis of Chiral Piperazin-2-ones as Model Peptidomimetics, J. Chem. Soc., 1989, 1687-1689.
Dutta, A.S., Potent Cyclic Monomeric and Dimeric Peptide, etc., Journal of Peptide Science, 2000, vol. 6, pp. 321-341, especially pp. 323-325, Table 1, compounds 47-58.
de Visser, Solid-phase synthesis of polymyxin B1 and analogues via, etc. P.C.J. Peptide Res., 2003, vol. 61, pp. 298-306, especially p. 303, Table 1, compounds 27-28.
Masuzawa et al., The Reaction of C-Substituted Ethylenediamine with the Ester of Alpha-Halo Acid, Apr. 1965, vol. 38, No. 12, pp. 2078-2081.
Shreder, K., et al, “Synthesis of a Constrained Enkephalin Analog to Illustrate a Novel Route to the Piperazinone Ring Structure”, Tetrahedron Letters, Elsevier, Amsterdam vol. 39, No. 3-4, Jan. 15, 1998, pp. 221-224, ISSN: 0040-4039.
Communication from European Patent Office in European Patent Application 07759821.7, dated Oct. 2, 2009, and including Supplementary European Search Report and European Search Opinion.
Goff D.A., et al: Tetrahedron Letters, Elsevier, Amsterdam, NL Lnkd.—DOI:10.1016/0040-4039(96)01382-2, vol. 37, No. 35, Aug. 26, 1996, pp. 6247-6250.
Shigematsu, N., et al.: “Structure and Synthesis of FR-900490 A New Immunomodulating Peptide Isolated From A Fungus” Tetrahedron Letters, vol. 29, No. 40, 1988, pp. 5147-5150.
Communication pursuant to Article 94(3) EPC in European Application No. 07759821.7, Jun. 8, 2010.
Bastos Margarita
Cai Hui-Zhi
Sharma Shubh D.
Yang Wei
Gudibande Satyanarayana R
Kosar Andrew D
Palatin Technologies Inc.
Slusher Stephen A.
LandOfFree
Amino acid surrogates for peptidic constructs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid surrogates for peptidic constructs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid surrogates for peptidic constructs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2682893